105
Views
8
CrossRef citations to date
0
Altmetric
Review

Managing comorbidities in idiopathic pulmonary fibrosis

&
Pages 309-318 | Published online: 22 Sep 2015

References

  • RaghuGCollardHREganJJAn official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and managementAm J Respir Crit Care Med2011183678882421471066
  • RaghuGWeyckerDEdelsbergJBradfordWZOsterGIncidence and prevalence of idiopathic pulmonary fibrosisAm J Respir Crit Care Med2006174781081616809633
  • RaghuGChenSYYehWSIdiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001–2011Lancet Respir Med20142756657224875841
  • GribbinJHubbardRBLe JeuneISmithCJWestJTataLJIncidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UKThorax2006611198098516844727
  • KingTEJrBradfordWZCastro-BernardiniSA phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosisN Engl J Med2014370222083209224836312
  • SchmidtSLNambiarAMTayobNPulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysemaEur Respir J201138117618321148225
  • RyersonCJHartmanTElickerBMClinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosisChest2013144123424023370641
  • AkagiTMatsumotoTHaradaTCoexistent emphysema delays the decrease of vital capacity in idiopathic pulmonary fibrosisRespir Med200910381209121519251407
  • JankowichMDRoundsSCombined pulmonary fibrosis and emphysema alters physiology but has similar mortality to pulmonary fibrosis without emphysemaLung2010188536537320614219
  • KurashimaKTakayanagiNTsuchiyaNThe effect of emphysema on lung function and survival in patients with idiopathic pulmonary fibrosisRespirology201015584384820546187
  • MoriKShiraiTMikamoMRespiratory mechanics measured by forced oscillation technique in combined pulmonary fibrosis and emphysemaRespir Physiol Neurobiol2013185223524023117106
  • MuraMZompatoriMPacilliAMFasanoLSchiavinaMFabbriMThe presence of emphysema further impairs physiologic function in patients with idiopathic pulmonary fibrosisRespir Care200651325726516533415
  • TasakaSMizoguchiKFunatsuYCytokine profile of bronchoalveolar lavage fluid in patients with combined pulmonary fibrosis and emphysemaRespirology201217581482022515655
  • ToddNWJeudyJLavaniaSCentrilobular emphysema combined with pulmonary fibrosis results in improved survivalFibrogenesis Tissue Repair201141621324139
  • MejiaMCarrilloGRojas-SerranoJIdiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertensionChest20091361101519225068
  • SuginoKIshidaFKikuchiNComparison of clinical characteristics and prognostic factors of combined pulmonary fibrosis and emphysema versus idiopathic pulmonary fibrosis aloneRespirology201419223924525198924
  • CottinVNunesHBrilletPYCombined pulmonary fibrosis and emphysema: a distinct underrecognised entityEur Respir J200526458659316204587
  • AntoniouKMWalshSLHansellDMSmoking-related emphysema is associated with idiopathic pulmonary fibrosis and rheumatoid lungRespirology20131881191119623819865
  • KishabaTShimaokaYFukuyamaHA cohort study of mortality predictors and characteristics of patients with combined pulmonary fibrosis and emphysemaBMJ Open201223
  • KitaguchiYFujimotoKHanaokaMKawakamiSHondaTKuboKClinical characteristics of combined pulmonary fibrosis and emphysemaRespirology201015226527120051048
  • LeeCHKimHJParkCMThe impact of combined pulmonary fibrosis and emphysema on mortalityInt J Tuberc Lung Dis20111581111111621740677
  • KewKMSeniukovichAInhaled steroids and risk of pneumonia for chronic obstructive pulmonary diseaseCochrane Database Syst Rev20143CD01011524615270
  • Idiopathic Pulmonary Fibrosis Clinical Research NetworkRaghuGAnstromKJKingTEJrLaskyJAMartinezFJPrednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosisN Engl J Med2012366211968197722607134
  • HubbardRVennALewisSBrittonJLung cancer and cryptogenic fibrosing alveolitis. A population-based cohort studyAm J Respir Crit Care Med200016115810619790
  • TomassettiSGurioliCRyuJHThe impact of lung cancer on survival of idiopathic pulmonary fibrosisChest2015147115716425166895
  • National Lung Screening Trial Research TeamAberleDRAdamsAMReduced lung-cancer mortality with low-dose computed tomographic screeningN Engl J Med2011365539540921714641
  • DetterbeckFCMazzonePJNaidichDPBachPBScreening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelinesChest20131435 Supple78Se92S23649455
  • KumarPGoldstrawPYamadaKPulmonary fibrosis and lung cancer: risk and benefit analysis of pulmonary resectionJ Thorac Cardiovasc Surg200312561321132712830051
  • MizunoYIwataHShirahashiKThe importance of intraoperative fluid balance for the prevention of postoperative acute exacerbation of idiopathic pulmonary fibrosis after pulmonary resection for primary lung cancerEur J Cardiothorac Surg2012416e161e16522504895
  • SakamotoSHommaSMunMFujiiTKurosakiAYoshimuraKAcute exacerbation of idiopathic interstitial pneumonia following lung surgery in 3 of 68 consecutive patients: a retrospective studyIntern Med2011502778521245629
  • SuzukiHSekineYYoshidaSRisk of acute exacerbation of interstitial pneumonia after pulmonary resection for lung cancer in patients with idiopathic pulmonary fibrosis based on preoperative high-resolution computed tomographySurg Today201141791492121748606
  • SugiuraHTakedaAHoshiTAcute exacerbation of usual interstitial pneumonia after resection of lung cancerAnn Thorac Surg201293393794322305054
  • ShintaniYOhtaMIwasakiTPredictive factors for postoperative acute exacerbation of interstitial pneumonia combined with lung cancerGen Thorac Cardiovasc Surg201058418218520401711
  • Perez-AlvarezRPerez-de-LisMDiaz-LagaresCInterstitial lung disease induced or exacerbated by TNF-targeted therapies: analysis of 122 casesSemin Arthritis Rheum201141225626421277618
  • TakedaAEnomotoTSanukiNAcute exacerbation of subclinical idiopathic pulmonary fibrosis triggered by hypofractionated stereotactic body radiotherapy in a patient with primary lung cancer and slightly focal honeycombingRadiat Med200826850450718975053
  • KenmotsuHNaitoTKimuraMThe risk of cytotoxic chemotherapy-related exacerbation of interstitial lung disease with lung cancerJ Thorac Oncol2011671242124621623239
  • ShorrAFWainrightJLCorsCSLettieriCJNathanSDPulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplantEur Respir J200730471572117626111
  • NathanSDShlobinOAAhmadSUrbanekSBarnettSDPulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosisChest2007131365766317356077
  • ModrykamienAMGudavalliRMcCarthyKParambilJEchocardiography, 6-minute walk distance, and distance-saturation product as predictors of pulmonary arterial hypertension in idiopathic pulmonary fibrosisRespir Care201055558458820420729
  • LettieriCJNathanSDBarnettSDAhmadSShorrAFPrevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosisChest2006129374675216537877
  • BoutouAKPitsiouGGTrigonisIExercise capacity in idiopathic pulmonary fibrosis: the effect of pulmonary hypertensionRespirology201116345145821122030
  • CorteTJWortSJGatzoulisMAMacdonaldPHansellDMWellsAUPulmonary vascular resistance predicts early mortality in patients with diffuse fibrotic lung disease and suspected pulmonary hypertensionThorax2009641088388819546096
  • SalajkaFBartosVNovosadJFailure of noninvasive prediction of pulmonary hypertension in patients with idiopathic pulmonary fibrosisMonaldi Arch Chest Dis201175317217722428220
  • NathanSDShlobinOABarnettSDRight ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosisRespir Med200810291305131018619825
  • ZismanDARossDJBelperioJAPrediction of pulmonary hypertension in idiopathic pulmonary fibrosisRespir Med2007101102153215917604151
  • ZismanDAKarlamanglaASKawutSMValidation of a method to screen for pulmonary hypertension in advanced idiopathic pulmonary fibrosisChest2008133364064518198245
  • MinaiOASantacruzJFAlsterJMBudevMMMcCarthyKImpact of pulmonary hemodynamics on 6-min walk test in idiopathic pulmonary fibrosisRespir Med2012106111613162122902266
  • PapakostaDPitsiouGDaniilZPrevalence of pulmonary hypertension in patients with idiopathic pulmonary fibrosis: correlation with physiological parametersLung2011189539139921660584
  • AndersenCUMellemkjærSHilbergONielsen-KudskJESimonsenUBendstrupEPulmonary hypertension in interstitial lung disease: prevalence, prognosis and 6 min walk testRespir Med2012106687588222425136
  • SwigrisJJOlsonALShlobinOAAhmadSBrownKKNathanSDHeart rate recovery after six-minute walk test predicts pulmonary hypertension in patients with idiopathic pulmonary fibrosisRespirology201116343944520946337
  • SwigrisJJSwickJWamboldtFSHeart rate recovery after 6-min walk test predicts survival in patients with idiopathic pulmonary fibrosisChest2009136384184819395579
  • ArcasoySMChristieJDFerrariVAEchocardiographic assessment of pulmonary hypertension in patients with advanced lung diseaseAm J Respir Crit Care Med2003167573574012480614
  • HamadaKNagaiSTanakaSSignificance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosisChest2007131365065617317730
  • JudgeEPFabreAAdamaliHIEganJJAcute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosisEur Respir J20124019310022135282
  • SongJWSongJKKimDSEchocardiography and brain natriuretic peptide as prognostic indicators in idiopathic pulmonary fibrosisRespir Med2009103218018619097877
  • NadrousHFPellikkaPAKrowkaMJPulmonary hypertension in patients with idiopathic pulmonary fibrosisChest200512842393239916236900
  • KimuraMTaniguchiHKondohYPulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosisRespiration201385645646323257350
  • GläserSObstAKochBPulmonary hypertension in patients with idiopathic pulmonary fibrosis – the predictive value of exercise capacity and gas exchange efficiencyPloS One201386e6564323840349
  • Rivera-LebronBNForfiaPRKreiderMLeeJCHolmesJHKawutSMEchocardiographic and hemodynamic predictors of mortality in idiopathic pulmonary fibrosisChest2013144256457023450321
  • RaghuGBehrJBrownKKTreatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trialAnn Intern Med2013158964164923648946
  • RaghuGMillion-RousseauRMorgantiAPerchenetLBehrJMUSIC Study GroupMacitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trialEur Respir J20134261622163223682110
  • KingTEJrBehrJBrownKKBUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosisAm J Respir Crit Care Med20081771758117901413
  • KingTEJrBrownKKRaghuGBUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosisAm J Respir Crit Care Med20111841929921474646
  • CorteTJKeirGJDimopoulosKBosentan in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumoniaAm J Respir Crit Care Med2014190220821724937643
  • Idiopathic Pulmonary Fibrosis Clinical Research NetworkZismanDASchwarzMA controlled trial of sildenafil in advanced idiopathic pulmonary fibrosisN Engl J Med2010363762062820484178
  • HanMKBachDSHaganPGSildenafil preserves exercise capacity in patients with idiopathic pulmonary fibrosis and right-sided ventricular dysfunctionChest201314361699170823732584
  • WallaertBMongeELe RouzicOWémeau-StervinouLSalleronJGrosboisJMPhysical activity in daily life of patients with fibrotic idiopathic interstitial pneumoniaChest201314451652165823928896
  • KotaniISatoAHayakawaHUranoTTakadaYTakadaAIncreased procoagulant and antifibrinolytic activities in the lungs with idiopathic pulmonary fibrosisThromb Res19957764935047624837
  • GüntherAMosaviPRuppertCEnhanced tissue factor pathway activity and fibrin turnover in the alveolar compartment of patients with interstitial lung diseaseThromb Haemost200083685386010896238
  • SprungerDBOlsonALHuieTJPulmonary fibrosis is associated with an elevated risk of thromboembolic diseaseEur Respir J201239112513221737559
  • SodeBFDahlMNielsenSFNordestgaardBGVenous thromboembolism and risk of idiopathic interstitial pneumonia: a nationwide studyAm J Respir Crit Care Med2010181101085109220167844
  • DalleywaterWPowellHAFogartyAWHubbardRBNavaratnamVVenous thromboembolism in people with idiopathic pulmonary fibrosis: a population-based studyEur Respir J20144461714171525323238
  • HubbardRBSmithCLe JeuneIGribbinJFogartyAWThe association between idiopathic pulmonary fibrosis and vascular disease: a population-based studyAm J Respir Crit Care Med2008178121257126118755924
  • KuboHNakayamaKYanaiMAnticoagulant therapy for idiopathic pulmonary fibrosisChest200512831475148216162746
  • KinderBWCollardHRKingTEJrAnticoagulant therapy and idiopathic pulmonary fibrosisChest2006130130230316840421
  • NothIAnstromKJCalvertSBA placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosisAm J Respir Crit Care Med20121861889522561965
  • RyersonCJBerkeleyJCarrieri-KohlmanVLPantilatSZLandefeldCSCollardHRDepression and functional status are strongly associated with dyspnea in interstitial lung diseaseChest2011139360961620688924
  • KrishnanVMcCormackMCMathaiSCSleep quality and health-related quality of life in idiopathic pulmonary fibrosisChest2008134469369818625669
  • MermigkisCBouloukakiIAntoniouKObstructive sleep apnea should be treated in patients with idiopathic pulmonary fibrosisSleep Breath201519138539125028171
  • MermigkisCStagakiETryfonSHow common is sleep-disordered breathing in patients with idiopathic pulmonary fibrosis?Sleep Breath201014438739020232261
  • LancasterLHMasonWRParnellJAObstructive sleep apnea is common in idiopathic pulmonary fibrosisChest2009136377277819567497
  • PihtiliABingolZKiyanECuhadarogluCIsseverHGulbaranZObstructive sleep apnea is common in patients with interstitial lung diseaseSleep Breath20131741281128823563999
  • LedererDJJelicSBasnerRCIshizakaABhattacharyaJCirculating KL-6, a biomarker of lung injury, in obstructive sleep apnoeaEur Respir J200933479379619336590
  • LedererDJJelicSBhattacharyaJBasnerRCIs obstructive sleep apnea a cause of idiopathic pulmonary fibrosis?Arch Pathol Lab Med20121365470 author reply 47022540293
  • MermigkisCBouloukakiIAntoniouKMCPAP therapy in patients with idiopathic pulmonary fibrosis and obstructive sleep apnea: does it offer a better quality of life and sleep?Sleep Breath20131741137114323386371
  • MulgrewATFoxNAyasNTRyanCFDiagnosis and initial management of obstructive sleep apnea without polysomnography: a randomized validation studyAnn Intern Med2007146315716617283346
  • FahimADettmarPWMoriceAHHartSPGastroesophageal reflux and idiopathic pulmonary fibrosis: a prospective studyMedicina (Kaunas)201147420020521829051
  • SavarinoECarboneRMarabottoEGastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patientsEur Respir J20134251322133123471347
  • Lozo VukovacELozoMMiseKBronchoalveolar pH and inflammatory biomarkers in newly diagnosed IPF and GERD patients: a case-control studyMed Sci Monit20142025526124535066
  • NothIZanganSMSoaresRVPrevalence of hiatal hernia by blinded multidetector CT in patients with idiopathic pulmonary fibrosisEur Respir J201239234435121737563
  • RaghuGFreudenbergerTDYangSHigh prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosisEur Respir J200627113614216387946
  • SweetMPPattiMGLeardLEGastroesophageal reflux in patients with idiopathic pulmonary fibrosis referred for lung transplantationJ Thorac Cardiovasc Surg200713341078108417382656
  • LeeJSRyuJHElickerBMGastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosisAm J Respir Crit Care Med2011184121390139421700909
  • LeeJSSongJWWoltersPJBronchoalveolar lavage pepsin in acute exacerbation of idiopathic pulmonary fibrosisEur Respir J201239235235822183478
  • TcherakianCCottinVBrilletPYProgression of idiopathic pulmonary fibrosis: lessons from asymmetrical diseaseThorax201166322623120880868
  • LeeJSCollardHRRaghuGDoes chronic microaspiration cause idiopathic pulmonary fibrosis?Am J Med2010123430431120362747
  • LeeJSCollardHRAnstromKJAnti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trialsLancet Respir Med20131536937624429201
  • RaghuGRochwergBZhangYAn Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice GuidelineAm J Respir Crit Care Med20151922e3e1926177183
  • KizerJRZismanDABlumenthalNPAssociation between pulmonary fibrosis and coronary artery diseaseArch Intern Med2004164555155615006833
  • KimWYMokYKimGWAssociation between idiopathic pulmonary fibrosis and coronary artery disease: a case-control study and cohort analysisSarcoidosis Vasc Diffuse Lung Dis201531428929625591140
  • DalleywaterWPowellHAHubbardRBNavaratnamVRisk factors for cardiovascular disease in people with idiopathic pulmonary fibrosis: a population-based studyChest2015147115015625121965
  • PonnuswamyAManikandanRSabetpourAKeepingIMFinnertyJPAssociation between ischaemic heart disease and interstitial lung disease: a case-control studyRespir Med2009103450350719196502
  • NathanSDBasavarajAReichnerCPrevalence and impact of coronary artery disease in idiopathic pulmonary fibrosisRespir Med201010471035104120199856
  • NathanSDWeirNShlobinOAThe value of computed tomography scanning for the detection of coronary artery disease in patients with idiopathic pulmonary fibrosisRespirology201116348148621199161
  • HyldgaardCHilbergOBendstrupEHow does comorbidity influence survival in idiopathic pulmonary fibrosis?Respir Med2014108464765324529739
  • KingTEJrAlberaCBradfordWZAll-cause mortality rate in patients with idiopathic pulmonary fibrosis. Implications for the design and execution of clinical trialsAm J Respir Crit Care Med2014189782583124476390
  • AkhtarAAAliMASmithRPDepression in patients with idiopathic pulmonary fibrosisChron Respir Dis201310312713323897928
  • HollandAEFioreJFJrBellECDyspnoea and comorbidity contribute to anxiety and depression in interstitial lung diseaseRespirology20141981215122125112470
  • De VriesJKesselsBLDrentMQuality of life of idiopathic pulmonary fibrosis patientsEur Respir J200117595496111488332
  • ElfferichMDDe VriesJDrentMType D or ‘distressed’ personality in sarcoidosis and idiopathic pulmonary fibrosisSarcoidosis Vasc Diffuse Lung Dis2011281657121796893
  • RyersonCJAreanPABerkeleyJDepression is a common and chronic comorbidity in patients with interstitial lung diseaseRespirology201217352553222221976
  • LamersFJonkersCCBosmaHChavannesNHKnottnerusJAvan EijkJTImproving quality of life in depressed COPD patients: effectiveness of a minimal psychological interventionCOPD20107531532220854045
  • KunikMEVeazeyCCullyJACOPD education and cognitive behavioral therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients: a randomized controlled trialPsychol Med200838338539617922939
  • RaynerLPriceAEvansAValsrajKHigginsonIJHotopfMAntidepressants for depression in physically ill peopleCochrane Database Syst Rev20103CD00750320238354
  • UsmaniZACarsonKVChengJNEstermanAJSmithBJPharmacological interventions for the treatment of anxiety disorders in chronic obstructive pulmonary diseaseCochrane Database Syst Rev201111CD00848322071851
  • RyersonCJCayouCToppFPulmonary rehabilitation improves long-term outcomes in interstitial lung disease: a prospective cohort studyRespir Med2014108120321024332409
  • NakayamaMBandoMArakiKPhysical activity in patients with idiopathic pulmonary fibrosisRespirology201520464064625728219
  • PittaFTroostersTSpruitMAProbstVSDecramerMGosselinkRCharacteristics of physical activities in daily life in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2005171997297715665324
  • PaffenbargerRSJrHydeRTWingALHsiehCCPhysical activity, all-cause mortality, and longevity of college alumniN Engl J Med1986314106056133945246
  • GaunaurdIAGómez-MarínOWRamosCFPhysical activity and quality of life improvements of patients with idiopathic pulmonary fibrosis completing a pulmonary rehabilitation programRespir Care201459121872187925185149
  • HollandAEHillCJConronMMunroPMcDonaldCFShort term improvement in exercise capacity and symptoms following exercise training in interstitial lung diseaseThorax200863654955418245143
  • SwigrisJJFaircloughDLMorrisonMBenefits of pulmonary rehabilitation in idiopathic pulmonary fibrosisRespir Care201156678378921333082
  • NishiyamaOKondohYKimuraTEffects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosisRespirology200813339439918399862
  • MartinezFJSafrinSWeyckerDThe clinical course of patients with idiopathic pulmonary fibrosisAnn Intern Med200514212 Pt 196396715968010